On May 6, 2019 NewLink Genetics Corporation (NASDAQ:NLNK) reported that the company will participate in the following investor and medical conferences (Press release, NewLink Genetics, MAY 6, 2019, View Source [SID1234535738]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Bank of America Merrill Lynch Global Health Care Conference 2019 on May 14-16 in Las Vegas

Management will present on Thursday, May 16 at 8:40 AM PT / 11:40 AM ET
Immuno-Oncology 2019 World Congress on May 23-24 in Barcelona, Spain

Poster presentation of Abstract #188 entitled, "A Phase 1 Clinical Trial of NLG802, a Prodrug of Indoximod with Enhanced Pharmacokinetic Properties"
A live webcast of the Bank of America Merrill Lynch Health Care Conference presentation will be available on the Company’s website at www.newlinkgenetics.com in the "Investors & Media" section under "Events and Presentations."

The poster to be presented at the Immuno-Oncology 2019 World Congress will be available on the Company’s website www.newlinkgenetics.com at 8:30 AM ET in the "Investors & Media" section under "Posters & Publications."